Clinical Trials Directory

Trials / Completed

CompletedNCT06247020

Metabolic Effects of Oral Sodium Butyrate Supplementation on Overweight Individuals

Metabolic Effects of Oral Sodium Butyrate Supplementation on Overweight Individuals: a Pilot Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Federico II University · Academic / Other
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Numerous evidences suggest an important role of short-chain fatty acids, produced by the intestinal fermentation of dietary fibers by the intestinal microbiota, in the modulation of various biological functions relevant to human health. In particular, butyrate, in addition to its trophic action on enterocytes, could improve insulin sensitivity and increase GLP-1 secretion, suggesting a possible role in the modulation of glucose metabolism. However, to date, very few randomized controlled trials (RCTs) have observed a significant increase in plasma butyrate concentrations in humans after nutritional interventions with high-fiber diets or foods. Butyrate occurs naturally in some foods, such as milk and dairy products, where it is often associated with sodium, becoming sodium butyrate. Therefore, recent studies suggest the use of oral sodium butyrate supplements in order to obtain a significant increase in butyrate plasma concentrations able to exert the potential beneficial effects related to them. To date, few studies have investigated the effect of oral sodium butyrate supplementation on glucose metabolism in healthy or overweight individuals, individuals at high cardiometabolic risk, and individuals with type 2 diabetes. Therefore, the purpose of this pilot study is to evaluate the effects of oral sodium butyrate supplementation, versus placebo, on glucose tolerance and insulin sensitivity in a group of overweight/obese individuals and the mechanisms underlying these effects.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSupplementation with sodium- butyrrateOral supplementation with sodium butyrrate capsules
DIETARY_SUPPLEMENTPlaceboOral supplementation with placebo capsules

Timeline

Start date
2022-02-24
Primary completion
2023-03-15
Completion
2023-06-13
First posted
2024-02-07
Last updated
2024-02-07

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06247020. Inclusion in this directory is not an endorsement.